Business NewsMarketWire • A2 Acquisition Corp. Announces TSXV Conditional Approval and the Increase of Medicenna Therapeutics Inc. Offering Size to $4,000,000

A2 Acquisition Corp. Announces TSXV Conditional Approval and the Increase of Medicenna Therapeutics Inc. Offering Size to $4,000,000

A2 Acquisition Corp. Announces TSXV Conditional Approval and the Increase of Medicenna Therapeutics Inc. Offering Size to $4,000,000

CALGARY, ALBERTA--(Marketwired - Feb. 27, 2017) -

View More : http://www.marketwired.com/mw/release.do?id=2198953&sourceType=3
Releted News by marketwire
Alaris Royalty Corp. Announces Timing of 2016 Year End Results, Conference Call and Webcast
A2 Acquisition Corp. Announces TSXV Conditional Approval and the Increase of Medicenna Therapeutics Inc. Offering Size to $4,000,000
Air Force Federal Credit Union Supports Military Saves Week